ARTICLE | Management Tracks
Amily Zhang becomes CMO at Antengene
Plus: Boussif joins Anjarium as CTO, and updates from Arch, OncoHealth and Vivante
December 9, 2022 1:23 AM UTC
Hematology and oncology company Antengene Corp. Ltd. (HKEX:6996) hired Amily Zhang as CMO, succeeding Kevin Lynch who will continue as an adviser. Zhang was VP, head of clinical development of oncology, corporate VP and CMO for oncology at Jiangsu Hengrui Medicine Co. Ltd. (Shanghai:600276), before which she held leadership roles for over a decade at Bayer AG (Xetra:BAYN).
Non-viral gene therapy company Anjarium Biosciences AG hired Otmane Boussif as CTO. Boussif was most recently CTO at Sensorion S.A. (Euronext:ALSEN), and previously held senior roles at Novartis AG (SIX:NOVN; NYSE:NVS), including as global head of cell and gene therapy technical development and global head of early phase development. ...